© 2008, Columbia Laboratories, Inc. All rights reserved.

 

Please note that the product information provided on this website is intended only for residents of the United States.

In IVF-ET cycles—

 

Once-daily Crinone 8% Provided Pregnancy Rates Comparable to Endometrin® BID/TID1

 

Study Design: Results of a prospective, randomized, multicenter trial of 1211 women receiving progesterone for an IVF-ET cycle. ICSI, assisted hatching, and co-culture also were allowed. Starting on the day of oocyte retrieval, patients received Crinone 8% (90 mg QD) or Endometrin (100 mg BID or TID).

 

Endometrin is a registered trademark of Ferring Pharmaceuticals.

 

Reference: 1. Doody K, Shamma N, Paulson R, Bayer S, Blake E, Yankov V. Endometrin® for luteal phase support in a randomized, controlled, open-label, prospective IVF clinical trial using a combination of Menopur® and Bravelle®. Fertil Steril. 2007;87(Suppl 2):S24. Abstract P-34.